PRESS RELEASE published on 06/26/2023 at 13:30, 2 years 8 months ago Irving Resources Announces Non-Brokered Private Placement
PRESS RELEASE published on 06/06/2023 at 18:40, 2 years 8 months ago Irving Resources Receives High-Grade Assays from Omui, Omu Project, Hokkaido, Japan
PRESS RELEASE published on 04/04/2023 at 14:00, 2 years 10 months ago Irving Resources Appoints Mr. Shuichi Miyatake as VP of Exploration and Alliance Project Manager, Irving Japan
PRESS RELEASE published on 03/06/2023 at 16:00, 2 years 11 months ago Irving Resources Intersects New High-Grade Au-Ag Veins at Hokuryu and Encounters Significant Vein System at Depth at Omui, Omu Project, Hokkaido, Japan
PRESS RELEASE published on 01/25/2023 at 14:00, 3 years 1 month ago Irving Resources Announces Commencement of 2023 Exploration Campaign
Published on 03/02/2026 at 17:40, 37 minutes ago Bioxytran, Inc. Reports Positive Phase 1b/2a Clinical Study Results for ProLectin-M, a Broad-Range Antiviral Drug in Mild to Moderate COVID-19
Published on 03/02/2026 at 16:00, 2 hours 17 minutes ago MWC 2026: Amdocs Announces Research Collaboration with Stanford Researchers to Study AI's Impact on Software Engineering Productivity
Published on 03/02/2026 at 15:22, 2 hours 55 minutes ago Silver Spruce Resources Inc. Announces Non-Brokered Private Placement for Proceeds of up to $2,000,000
Published on 03/02/2026 at 15:00, 3 hours 17 minutes ago Norsemont Targets Filing Environmental Impact Declaration in December 2026
Published on 03/02/2026 at 18:05, 11 minutes ago Huawei Cloud Summit at MWC26: Solving Industry Challenges with AI
Published on 03/02/2026 at 17:25, 51 minutes ago Huawei Releases the Fully Connected Industrial Networks Report, Aiming to Promote the Upgrade of Smart Factory Architecture
Published on 03/02/2026 at 16:35, 1 hour 41 minutes ago Skyhawk Announces Australia's Therapeutic Goods Administration Has Determined SKY-0515 for Huntington's Disease Meets Eligibility Criteria for Registration via the Provisional Approval Pathway
Published on 03/02/2026 at 16:25, 1 hour 51 minutes ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Published on 03/02/2026 at 17:35, 42 minutes ago Disclosure of transactions in own shares from February 23 to February 27, 2026
Published on 03/02/2026 at 08:45, 9 hours 32 minutes ago Imerys: 2025 consolidated financial statements
Published on 02/27/2026 at 23:00, 2 days 19 hours ago Biophytis increases to €2 million the ceiling of its bond facility with Hexagon Capital Fund
Published on 02/27/2026 at 18:02, 3 days ago AXA: Execution of a share repurchase agreement in relation to AXAs share buy-back program of up to Euro 1.25 billion
